GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Archived. This submission is more than a year old. Votes and new comments are closed, and some of the advice in it may have been superseded — check the community wiki for the current version.
4k
c/compounding·posted 1 year ago by u/hassan_chowdhury

three years of 503A threads, summarised so you do not have to read them

Discussion Receipts ×4 Long Haul ×2 Sourced ×3

Right, the API source question again, but with numbers this time.

I have 9 data points over 40 weeks. The pattern is consistent enough that I do not think it is chance, and boring enough that nobody is going to screenshot it, which is usually a good sign.

The thing I would flag for anyone new: the effect I am describing showed up at week 37, not week 86. People give up long before the interesting part.

Interested in whether this matches other people's logs or whether I am an outlier.

6,459 up / 2,479 down72% upvoted34 commentsid 1np0pd20 Dec 2024

34 comments

28 in this archive, depth 5

best — the order this archive was captured in

u/prior_auth_painappeals434 points·1 year ago

I am going to push back on this slightly.

replysharereportpermalink
u/neha_krastev117 points·1 year ago

no pharmacy referral codes, naming is fine, recruiting is not

replysharereportpermalink
u/ferran_mensah63 points·1 year ago

What is the actual shortage list status right now?

replysharereportpermalink
u/naomi_erdogan-35 points·1 year ago

the the UK situation is different from the US, different regulations

replysharereportpermalink
u/ignacio_vanhecke355 points·1 year ago

Yeah, 503A and 503B are different regulatory animals.

replysharereportpermalink
u/formulary_fighterappeals224 points·1 year ago

What is the actual shortage list status right now?

replysharereportpermalink
u/hugo_bergstrom265 points·1 year ago

API transparency is the question that separates good compounders from sketchy ones

replysharereportpermalink
u/ahmed_fonseca111 points·1 year ago

The confident tone is doing a lot of work that the evidence is not.

replysharereportpermalink
u/food_noise_gonemaintenance220 points·1 year ago

Strongly agree. API source transparency matters.

replysharereportpermalink
[deleted]81 points·1 year ago

[deleted]

replysharereportpermalink
u/nadia_fonseca153 points·1 year ago

Titration speed is a side-effect dial far more than an efficacy dial.

replysharereportpermalink
u/hassan_chowdhuryOP97 points·1 year ago

The 503A pharmacy I used lost their shortage list eligibility. Same day, compounding became illegal. Rules are real.

replysharereportpermalink
u/anya_antonsen35 points·1 year ago

Did they tell you their API source or dodge the question?

replysharereportpermalink
u/hassan_chowdhuryOP26 points·1 year ago

state board rules differ, say which state

replysharereportpermalink
u/tb500_tangent118 points·1 year ago

regulatory claims need a citation to the actual rule, not interpretation

replysharereportpermalink
u/gallbladder_gary28 points·1 year ago

regulatory claims need a citation to the actual rule, not interpretation

Yes, exactly this, and it is the bit that took me 66 weeks to accept.

replysharereportpermalink
u/blunt_coldbox_notes23 points·1 year ago

Not to be pedantic but API source and shortage list are being used interchangeably and they are not interchangeable in real life.

replysharereportpermalink
u/gustav_cardoso111 points·1 year ago

The 503A pharmacy I used lost their shortage list eligibility. Same day, compounding became illegal. Rules are real.

replysharereportpermalink
u/usp_appendixMOD40 points·1 year ago

Removed a chain here. The rule is one line long and it is not negotiable.

replysharereportpermalink
u/priya_palacios24 points·1 year ago

API transparency is the question that separates good compounders from sketchy ones

replysharereportpermalink
u/neha_krastev19 points·1 year ago

Not to be pedantic but telehealth and state board are being used interchangeably and they are not interchangeable in real life.

replysharereportpermalink
u/zaid_grimaldi22 points·1 year ago

You have restated the marketing copy. What is the actual substance here.

replysharereportpermalink
u/milos_mensa74 points·1 year ago

Did they tell you their API source or dodge the question?

replysharereportpermalink
u/receptor_bias_rick18 points·1 year ago

No. This is the kind of confident post that gets copied into a screenshot and repeated for years. Where is the evidence.

replysharereportpermalink
u/ayesha_radich62 points·1 year ago

API transparency is the question that separates good compounders from sketchy ones

replysharereportpermalink
u/liv_vukovic50 points·1 year ago

the 503A/503B distinction is load-bearing, do not blur it

replysharereportpermalink
u/naomi_erdogan15 points·1 year ago

No. This is the kind of confident post that gets copied into a screenshot and repeated for years. Where is the evidence.

replysharereportpermalink
u/hassan_chowdhuryOP59 points·1 year ago

The 503A pharmacy I used lost their shortage list eligibility. Same day, compounding became illegal. Rules are real.

replysharereportpermalink
Permalinked branches
Deep branches get their own page so a single reply chain can be linked and read on its own.
About c/compounding

Compounded GLP-1s as a supply route: the 503A/503B distinction, the shortage-list mechanics that made compounding legal and then didn't, state board rules, telehealth prescriber models, and what a compounding pharmacy will and will not tell you about its API source.

53kmembers
95submissions
Oct 2023created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
c/compounding rules
  1. Regulatory claims need a citation to the actual rule, notice or docket.
  2. No pharmacy referral codes. Naming a pharmacy is fine; recruiting for it is not.
  3. API source questions are on-topic and pharmacies dodging them is newsworthy.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.